Market Overview

UPDATE: Columbia Laboratories Buys Back 1.4M Shares of Common Stock from Actavis at $6.08/Share

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Guidance Buybacks Global

 

Related Articles (CBRX + ACT)

Loading...